Lea Doppelbauer

Lea Doppelbauer

Auto-generated profile, based on publicly available information

Lea Doppelbauer

Department of Gynecology with Breast Center, Charité –Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2026 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
LDLea Doppelbauer
Lea Doppelbauer
MKMaria Margarete Karsten
Maria Margarete Karsten
ATAnna Tatzber
Anna Tatzber
LHLaura Hatzler
Laura Hatzler
PGPimrapat Gebert
Pimrapat Gebert
TPTherese Pross
Therese Pross
Background: Patient-reported outcomes (PROs) improve cancer care by enabling structured self-assessment of disease-related symptoms, overall functioning, and health-related quality of life. Despite proven benefits, routine use is still limited, in part due to suboptimal data visualization. Methodology: In a sub-study of the multicenter PRO B trial (52 centers, 924 patients with metastatic breast cancer), an interdisciplinary team of clinicians, researchers, patient representatives, and service designers co-developed user-centered PRO visualizations. Drawing on a literature review, an analysis of existing tools, and iterative mock-up development, the team generated initial design concepts. These concepts were then evaluated in semi-structured interviews with eight patients and five providers to assess clarity, emotional impact, usability, and potential for implementation. The interview data were analyzed thematically using a mixed deductive-inductive approach. Results: Eight key themes emerged: axis labeling, color schemes, background lines, alert representation, reference data, missing data, format/additional information, and practical application. Preferences included clear labels, consistent directionality, and simple alert markers. Color views diverged: traffic-light schemes were intuitive to some, but evoked negative reactions; blue gradients were perceived as neutral. Reference data aided context for some but discouraged others, supporting optional display. Missing values required consistent marking. Patients preferred access via both paper and customizable digital tools. Conclusions: Co-designed, user-centered visualizations enhance PRO interpretability, emotional acceptability, and clinical utility. Implementing these recommendations can strengthen communication, support shared decision-making, and promote patient-centered cancer care.

20 December 2025 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
LDLea Doppelbauer
Lea Doppelbauer
AHAnna Maria Hage
Anna Maria Hage
MKMaria Margarete Karsten
Maria Margarete Karsten
PGPimrapat Gebert
Pimrapat Gebert
ATAnna Tatzber
Anna Tatzber
TPTherese Pross
Therese Pross
Background: Patient-reported outcomes (PROs) are increasingly recognized as valuable data to enhance communication and support shared decision-making in cancer care. Despite evidence of their positive effects, few concrete approaches exist for the design and presentation of PRO visualizations. Even in high-incidence cancers such as breast cancer, limited knowledge is available on how patients perceive and interpret graphical displays of PRO results. This study evaluated different visualization formats of PRO data, that had been co-designed with patients and healthcare providers within the PRO B study, a large randomized controlled trial investigating alert-based PRO monitoring in patients with metastatic breast cancer. Methodology: After completion of the PRO B study, patients from both intervention and control group received a paper-based questionnaire together with their individual PRO data report featuring visualizations developed in a preceding design study. Survey items assessed comprehensibility, usefulness, and preferences regarding specific visualization features using Likert scales. Analyses included Mann-Whitney U tests for Likert scale answers, Pearson’s Chi-squared tests for categorical variables and two-sided independent-samples t-tests for numeric variables. Results: We collected feedback from 276 participants of the PRO B study. The findings demonstrate a strong overall endorsement on the clarity, emotional appropriateness and usefulness of the suggested graphical displays. Results highlight their potential for enhancing patient empowerment through improved self-awareness and better patient-provider communication. Conclusions: The positive feedback from PRO B study participants validate the suggested design concepts of PRO data and underscores their valuable role in making these outcomes more accessible, meaningful, and actionable for patients. These data provide the base for developing more flexible, interactive digital tools for routine care. Trial registration: DRKS00024015 Registered 15.02.2021 https://drks.de/search/de/trial/DRKS00024015/details .

10 February 2026 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
EVElfi M. Verheul
Elfi M. Verheul
MKMaria Margarete Karsten
Maria Margarete Karsten
PGPimrapat Gebert
Pimrapat Gebert
LDLea Doppelbauer
Lea Doppelbauer
SBSimona Borstnar
Simona Borstnar
MWMichel W. Wouters
Michel W. Wouters
Predictions of Health-Related Quality of Life (HRQoL) outcomes could support realistic recovery expectations after breast cancer (BC) surgery. We aimed to develop and validate prediction models for HRQoL outcomes after BC surgery. We used three datasets of BC patients from Berlin, Germany; Ljubljana, Slovenia; and Rotterdam; Netherlands. We included non-metastasised patients who were surgically treated for an initial diagnosis of BC and completed pre- and postoperative validated questionnaires. We used linear mixed models to analyse 15 domains of the EORTC QLQ-C30 and EORTC QLQ-BR23 over a two-year horizon. Baseline domain score (measured pre-operatively), age, BMI, smoking, TN stage, receptor status, neoadjuvant chemotherapy, axillary surgery and surgery type (breast-conserving, mastectomy, and immediate implant-based reconstruction) were included as predictors. Predictive performance at validation was assessed by the proportion of variance explained (marginal R2; mR2). We included N = 795 patients from Germany for development and N = 623 from Slovenia and N = 417 from Netherlands for validation. The largest proportion of variance was explained by the prediction models for sexual functioning (SF, mR2 35%), physical functioning (PF, mR2 29%), body image (BI, mR2 26%), and cognitive functioning (CF, mR2 25%). The models captured meaningfully different trends over time for different outcomes and surgery types. The predictive performance of the models was largely driven by the baseline domain score. Performance was reasonable at external validation, with r2 values of 19-33% for PF, 10-17% for CF, 15-18% for BI, and 22-28% for SF, although some other outcomes (e.g. breast symptoms and role functioning) showed miscalibration, indicating a need for recalibration. HRQoL after breast cancer surgery can be predicted using simple models with baseline domain scores and surgery type, demonstrating a new opportunity for Patient-Reported Outcome Measures (PROMs) in personalized care.